Haikou Affiliated Hospital Of Central South University Xiangya School Of Medicine
Clinical trials sponsored by Haikou Affiliated Hospital Of Central South University Xiangya School Of Medicine, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a safer dose of an old drug shield vulnerable children from deadly fungal infections? Results expected Feb 2027 (estimated)
-
Can a safer dose of an old drug shield vulnerable children from deadly fungal infections?
Disease control Recruiting nowThis trial tests whether a low dose of the antifungal drug liposomal amphotericin B can prevent invasive fungal infections in children aged 3 to 17 who have prolonged neutropenia (very low white blood cell counts) after cancer treatment or stem cell transplant. The drug is given …
Sponsor: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
Prevention Recruiting nowThis study looks at whether a low dose of the antifungal drug liposomal amphotericin B can prevent serious fungal infections in adults with blood cancers or who have had stem cell transplants and have a prolonged low white blood cell count (neutropenia). The trial enrolls 30 pati…
Sponsor: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine • Aim: Prevention
Last updated Aug 15, 2026 00:00 UTC